BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31425936)

  • 1. Tumor-infiltrating CD4
    Franzoni MS; Brandi A; de Oliveira Matos Prado JK; Elias F; Dalmolin F; de Faria Lainetti P; Prado MCM; Leis-Filho AF; Fonseca-Alves CE
    Res Vet Sci; 2019 Oct; 126():29-36. PubMed ID: 31425936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates.
    Estrela-Lima A; Araújo MS; Costa-Neto JM; Teixeira-Carvalho A; Barrouin-Melo SM; Cardoso SV; Martins-Filho OA; Serakides R; Cassali GD
    BMC Cancer; 2010 Jun; 10():256. PubMed ID: 20525350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding of the immunological heterogeneity of canine mammary carcinomas to provide immunophenotypic features of circulating leukocytes as clinically relevant prognostic biomarkers.
    Estrela-Lima A; Araújo MS; da Costa-Neto JM; Ribeiro LG; Damasceno KA; D'Assis MJ; Martins-Filho OA; Teixeira-Carvalho A; Serakides R; Cassali GD
    Breast Cancer Res Treat; 2012 Feb; 131(3):751-63. PubMed ID: 21448671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of blood T-lymphocyte subpopulations involved in host cellular immunity in dogs with mammary cancer.
    Karayannopoulou M; Anagnostou T; Margariti A; Kostakis C; Kritsepi-Konstantinou M; Psalla D; Savvas I
    Vet Immunol Immunopathol; 2017 Apr; 186():45-50. PubMed ID: 28413049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-lymphocytic infiltrate in canine mammary tumours: clinic and prognostic implications.
    Carvalho MI; Pires I; Prada J; Queiroga FL
    In Vivo; 2011; 25(6):963-9. PubMed ID: 22021690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER-2, EGFR, Cox-2 and Ki67 expression in lymph node metastasis of canine mammary carcinomas: Association with clinical-pathological parameters and overall survival.
    Araújo MR; Campos LC; Damasceno KA; Gamba CO; Ferreira E; Cassali GD
    Res Vet Sci; 2016 Jun; 106():121-30. PubMed ID: 27234549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory cell infiltration of tumors: Jekyll or Hyde.
    Talmadge JE; Donkor M; Scholar E
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):373-400. PubMed ID: 17717638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of tumor-infiltrating immune cells in spontaneous canine mammary gland tumor: 140 cases.
    Saeki K; Endo Y; Uchida K; Nishimura R; Sasaki N; Nakagawa T
    J Vet Med Sci; 2012 Feb; 74(2):227-30. PubMed ID: 21937855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.
    de Araújo MR; Campos LC; Ferreira E; Cassali GD
    J Vet Intern Med; 2015; 29(5):1360-7. PubMed ID: 26130166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the inflammatory tumor microenvironment and different histologic types of canine mammary tumors.
    de Souza TA; de Campos CB; De Biasi Bassani Gonçalves A; Nunes FC; Monteiro LN; de Oliveira Vasconcelos R; Cassali GD
    Res Vet Sci; 2018 Aug; 119():209-214. PubMed ID: 29966962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
    Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
    Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Occult Isolated Tumour Cells within Regional Lymph Nodes of Dogs with Malignant Mammary Tumours.
    Coleto AF; Wilson TM; Soares NP; Gundim LF; Castro IP; Guimarães EC; Bandarra MB; Medeiros-Ronchi AA
    J Comp Pathol; 2018 Jan; 158():32-38. PubMed ID: 29422313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.
    Wang K; Shen T; Siegal GP; Wei S
    Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study.
    Sihto H; Böhling T; Kavola H; Koljonen V; Salmi M; Jalkanen S; Joensuu H
    Clin Cancer Res; 2012 May; 18(10):2872-81. PubMed ID: 22467679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between major histocompatibility complex class I expression and prognosis in canine mammary gland tumors.
    Tanaka T; Shimada T; Akiyoshi H; Shimizu J; Zheng C; Yijyun L; Mie K; Hayashi A; Kuwamura M; Hoshi F; Ohashi F
    J Vet Med Sci; 2013 Oct; 75(10):1393-8. PubMed ID: 23728200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of a new histological and molecular-based classification of canine mammary neoplasia.
    Im KS; Kim NH; Lim HY; Kim HW; Shin JI; Sur JH
    Vet Pathol; 2014 May; 51(3):549-59. PubMed ID: 24003019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD204-Expressing Tumor-Associated Macrophages Are Associated With Malignant, High-Grade, and Hormone Receptor-Negative Canine Mammary Gland Tumors.
    Seung BJ; Lim HY; Shin JI; Kim HW; Cho SH; Kim SH; Sur JH
    Vet Pathol; 2018 May; 55(3):417-424. PubMed ID: 29343199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, expression of adipocytokines, and macrophage infiltration in canine mammary tumors.
    Lim HY; Im KS; Kim NH; Kim HW; Shin JI; Sur JH
    Vet J; 2015 Mar; 203(3):326-31. PubMed ID: 25641553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
    Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
    J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.